Clinical Trial Update: Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating caspofungin acetate for treating aspergillosis in patients with hematologic cancer or after stem cell transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis

Drugs mentioned

• Cancidas (caspofungin)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Cancer | Phase 2 | Status: COMPLETED